OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A New Approach for Loading Anticancer Drugs Into Mesenchymal Stem Cell-Derived Exosome Mimetics for Cancer Therapy
S Kalimuthu, Prakash Gangadaran, Ramya Lakshmi Rajendran, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 228

Showing 1-25 of 228 citing articles:

The emerging role of exosomes in mental disorders
Saumeh Saeedi, Sonia Israel, Corina Nagy, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 340

Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer
Zhijie Weng, Bowen Zhang, Chenzhou Wu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 264

Bioinspired exosome-like therapeutics and delivery nanoplatforms
Mei Lu, Yuanyu Huang
Biomaterials (2020) Vol. 242, pp. 119925-119925
Closed Access | Times Cited: 232

Artificial exosomes for translational nanomedicine
Yongjiang Li, Junyong Wu, Jihua Liu, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 232

<p>Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate</p>
Juntang Shao, Jennica L. Zaro, Yuxian Shen
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 9355-9371
Open Access | Times Cited: 221

The role of exosomal noncoding RNAs in cancer
Yan Xie, Wei Dang, Siwei Zhang, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 214

Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential
Zhengjun Lin, Yanlin Wu, Yiting Xu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 184

Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications
Md Nurul Huda, Md Nafiujjaman, Isaac G. Deaguero, et al.
ACS Biomaterials Science & Engineering (2021) Vol. 7, Iss. 6, pp. 2106-2149
Open Access | Times Cited: 182

Exosomes as a next-generation drug delivery system: An update on drug loading approaches, characterization, and clinical application challenges
Fatemeh Mehryab, Shahram Rabbani, Soraya Shahhosseini, et al.
Acta Biomaterialia (2020) Vol. 113, pp. 42-62
Closed Access | Times Cited: 158

Exosomal microRNAs derived from mesenchymal stem cells: cell-to-cell messages
Kasra Asgarpour, Zahra Shojaei, Fatemeh Amiri, et al.
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 154

Exosomes as drug delivery systems: A brief overview and progress update
Suyash M. Patil, Shruti S. Sawant, Nitesh K. Kunda
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 154, pp. 259-269
Closed Access | Times Cited: 152

The multifaceted role of mesenchymal stem cells in cancer
Michael Timaner, Kelvin K. Tsai, Yuval Shaked
Seminars in Cancer Biology (2019) Vol. 60, pp. 225-237
Closed Access | Times Cited: 150

Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes
Byung‐Chul Lee, Insung Kang, Kyung–Rok Yu
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 711-711
Open Access | Times Cited: 143

Mesenchymal stem cells as a double-edged sword in tumor growth: focusing on MSC-derived cytokines
Wenqing Liang, Xiaozhen Chen, Songou Zhang, et al.
Cellular & Molecular Biology Letters (2021) Vol. 26, Iss. 1
Open Access | Times Cited: 137

Technological advances towards extracellular vesicles mass production
Alice Grangier, Julien Branchu, Jeanne Volatron, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113843-113843
Open Access | Times Cited: 111

Exosomes and extracellular vesicles: Rethinking the essential values in cancer biology
Akira Yokoi, Takahiro Ochiya
Seminars in Cancer Biology (2021) Vol. 74, pp. 79-91
Open Access | Times Cited: 110

Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives
Srijita Sen, Joyal Xavier, Nitesh Kumar, et al.
3 Biotech (2023) Vol. 13, Iss. 3
Open Access | Times Cited: 86

Extracellular‐Vesicle‐Based Drug Delivery Systems for Enhanced Antitumor Therapies through Modulating the Cancer‐Immunity Cycle
Tuying Yong, Zhaohan Wei, Lu Gan, et al.
Advanced Materials (2022) Vol. 34, Iss. 52
Closed Access | Times Cited: 85

A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy
Jian Li, Ye Zhang, Pei-Yu Dong, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115087-115087
Open Access | Times Cited: 62

Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications
Jiaqi Tian, Zhengpu Han, Dandan Song, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 7923-7940
Open Access | Times Cited: 61

Leveraging nature’s nanocarriers: Translating insights from extracellular vesicles to biomimetic synthetic vesicles for biomedical applications
Yunxi Chen, Noélie Douanne, T.-C. Wu, et al.
Science Advances (2025) Vol. 11, Iss. 9
Closed Access | Times Cited: 3

Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics
Hyo‐Suk Kim, Eun Hye Kim, Gijung Kwak, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 14-14
Open Access | Times Cited: 116

Extracellular Vesicles as Natural, Safe and Efficient Drug Delivery Systems
Federico Villa, Rodolfo Quarto, Roberta Tasso
Pharmaceutics (2019) Vol. 11, Iss. 11, pp. 557-557
Open Access | Times Cited: 109

Recent Advances in Exosome-Based Drug Delivery for Cancer Therapy
Hyo‐Suk Kim, Hochung Jang, Haeun Cho, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4435-4435
Open Access | Times Cited: 102

Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges
Myoung Woo Lee, Somi Ryu, Dae Seong Kim, et al.
Leukemia (2019) Vol. 33, Iss. 3, pp. 597-611
Open Access | Times Cited: 98

Page 1 - Next Page

Scroll to top